Archer Aviation (ACHR) Raises $650M, Moves to Buy Hawthorne Airport for $126M; Shares Slip After Q3 Update

7 November 2025

Archer Aviation Inc. (NYSE: ACHR) unveiled a multi‑pronged update tied to its third‑quarter results: a $650 million equity raise, a deal to acquire control of Los Angeles’ Hawthorne Airport for $126 million, fresh flight‑test milestones for its Midnight eVTOL, and the closing of its Lilium patent portfolio purchase. The stock traded around $8.88 mid‑day as investors digested the capital raise and airport plan. ^[1]

What happened today

Archer to acquire control of Hawthorne Airport (HHR) for $126M. The company signed definitive agreements to gain control of the 80‑acre field (Jack Northrop Field) just under three miles from LAX. Archer says Hawthorne will anchor its planned Los Angeles air‑taxi network and serve as an AI operations testbed, including AI‑powered traffic and ground‑ops management. The transaction remains subject to closing conditions and city approval. ^[2]
Structure matters: Archer is assuming the master ground lease, not buying the land outright. The ground lease with the City of Hawthorne runs through 2055, and the company lists additional capital projects planned at the site as part of an “airport of the future” build‑out. ^[3]
$650M primary equity raise. Archer filed a 424B5 prospectus supplement for 81,250,000 new shares priced at $8.00 per share (gross proceeds $650M). After the issuance, total Class A shares outstanding are listed at ~732.5 million. A separate prospectus covers up to ~$27.6M of additional shares to settle a contractual payment in stock. ^[4]
Q3 2025 highlights. GAAP net loss was $129.9M; adjusted EBITDA loss was $116.1M. Archer reported $1.64B in cash, cash equivalents, and short‑term investments at quarter‑end and guided Q4 adjusted EBITDA loss to $110–$140M. ^[5]
Flight‑test and IP milestones. Midnight completed a 55‑mile piloted flight (31 minutes, >126 mph) and a 10,000‑ft altitude flight; Archer also closed the Lilium patent portfolio acquisition, taking its global IP assets to >1,000. ^[6]

Why Hawthorne matters

HHR’s location—near LAX, SoFi Stadium, the Intuit Dome, The Forum, and Downtown LA—makes it a strategic hub for short‑hop urban missions Archer is targeting ahead of the LA28 Olympic Games. Industry coverage notes the airport is slated to be the central node of Archer’s LA network and a staging area for 2028 operations, subject to approvals. ^[7]

Important fine print: Archer emphasizes it will assume the master lease (not purchase the land), with lease renewal risk and capex obligations to transform the site. The company also flags execution and certification risks in the prospectus. ^[8]

Certification & production: where things stand

Archer says it is largely through Phase 3 of the FAA type‑certification program and is focusing on Phase 4 (implementation and formal TIA testing). The company estimates it has received ~15% of compliance verification documents in that final phase. Archer also notes it holds a Part 135 air carrier certificate and is producing six Midnight aircraft across U.S. facilities for testing, certification, and non‑U.S. launch‑edition programs. ^[9]

Internationally, Archer highlights test and demonstration flights in the UAE and new airline partnerships in Korea (Korean Air) and Japan (JAL/Soracle JV), with some agreements still conditional. ^[10]

The market’s read so far

Stock reaction: ACHR traded near $8.88 mid‑day Friday after the update (see live chart above). Early headlines framed premarket softness around investor debate over the airport deal and ongoing cash burn. ^[11]
Analysts:JPMorgan cut its price target to $8 (Neutral) after the Q3 print; Needham reiterated Buy but trimmed its target to $10. ^[12]
Flows:ARK Invest disclosed buying over 3 million ACHR shares on Nov. 6 across multiple funds, according to portfolio‑tracking outlets and financial media. ^[13]

By the numbers (Q3 and recent moves)

Equity raised:$650M via 81.25M shares at $8.00 (primary registered direct). Shares outstanding post‑deal: ~732.5M. ^[14]
Cash & investments:$1.64B at Sept. 30, 2025 (liquidity now > $2B with the new raise, per company). ^[15]
P&L:GAAP net loss $129.9M; adjusted EBITDA loss $116.1M. Q4 adj. EBITDA guide: loss of $110–$140M. ^[16]
Hawthorne Airport:80 acres; ~190,000 sq ft of facilities; <3 miles from LAX; AI testbed designation. Acquisition of control via master lease assumption pending city approvals; lease through 2055. ^[17]
Technology/IP:>1,000 global IP assets after Lilium patent purchase (≈300 assets). ^[18]
Flight tests: Longest piloted flight 55 miles (31 min); top altitude 10,000 ft. ^[19]

Context: Archer’s LA ambitions and airline ties

Archer has been building a Los Angeles network blueprint, with LA28 Olympics ties previously announced in mainstream coverage. The company also keeps close airline partnerships (e.g., United Airlines) for integrating urban air mobility into existing air networks. ^[20]

Industry outlets underscore how pinning a near‑LAX base could streamline airport‑to‑city eVTOL trips—the core, high‑frequency routes urban air mobility depends on—while providing Archer a controlled environment to trial AI‑enabled operations at scale. ^[21]

What to watch next

City of Hawthorne approvals & closing of the airport transaction; specifics on capex and redevelopment timeline at HHR. ^[22]
Equity issuance settlement and any subsequent updates on capital allocation (the 424B5s outline both the $650M primary and a separate stock‑for‑services issuance). ^[23]
FAA certification cadence (transition into TIA testing within Phase 4) and Production Certificate progress. ^[24]
International ramp, including UAE launch‑edition activities and the Korean Air/Japan partnerships once definitive terms are finalized. ^[25]
Analyst and fund flows as markets recalibrate on dilution, execution at HHR, and certification timelines. ^[26]

Reporting notes & sources

Company press release (Nov. 6, 2025): airport acquisition, Q3 metrics, liquidity, flight milestones, and global pipeline. ^[27]
SEC filings (Nov. 6–7, 2025):424B5 for 81.25M shares @ $8.00 and separate 424B5 for stock in lieu of cash payments; details on lease structure, lease term to 2055, certification progress, and risk factors. ^[28]
Industry coverage:FlightGlobal and Aviation Week on the Hawthorne strategy and LA28 planning context. ^[29]
Market/analyst reactions:JPMorgan to $8 (Neutral) and Needham to $10 (Buy). ^[30]
Fund flows:ARK Invest large purchase reported by financial media. ^[31]

Archer Aviation Stock The Next Tesla of the Skies | #space #facts #stockmarket #evtol #automobile

Watch this video on YouTube.

References

Tags:

Mateusz Kaczmarek Latest posts

A technology and finance expert writing for TS2.tech. He analyzes developments in satellites, telecommunications, and artificial intelligence, with a focus on their impact on global markets. Author of industry reports and market commentary, often cited in tech and business media. Passionate about innovation and the digital economy.

View all

CNH Industrial Q3 Earnings Miss; Zacks Rank #4 Sell Signals Near-Term Underperformance
November 7, 2025, 11:02 AM EST. CNH Industrial (CNH) reported Q3 EPS of $0.08, missing the Zacks Consensus of $0.13 and down from $0.24 a year ago. After adjustments, the miss is -38.46%. The company posted revenue of $4.4B, beating the consensus by 2.21%. In the last four quarters, CNH beat estimates twice. The stock carries a Zacks Rank #4 (Sell), reflecting unfavorable near-term earnings revisions. Management commentary on the earnings call will dictate sentiment. Looking ahead, the current consensus calls for $0.16 per share on $4.78B in next quarter revenue and $0.57 on $17.62B for the current fiscal year. Year-to-date, CNH has declined about 9.4% versus the S&P 500's gain.
Hologic's Breast Health Rebounds as Buyout Talks Intensify
November 7, 2025, 11:00 AM EST. Hologic's Breast Health segment rebound anchors the stock narrative after Q4 FY2025, with revenues up 4.8% to $393.7 million driven by interventional products, the Endomagnetics addition, and improved U.S. sales execution. On an organic basis, growth still held at 3.3% excluding the divested SSI and Endomagnetics July impact. The year featured leadership changes to sharpen the go-to-market, rebalancing the sales force between capital and disposable lines and rolling out an end-of-life plan for older gantries. A North America direct-sales push for Endomagnetics broadened distribution. In late October, Hologic disclosed a proposed buyout by private equity firms Blackstone and TPG, valuing the deal at up to $79 per share with a CVR of up to $3, payable on 2026-2027 revenue milestones, shifting strategic emphasis onto the division.
BMO Capital Markets raises Lyft price target to $23 with market perform rating
November 7, 2025, 10:58 AM EST. BMO Capital Markets boosted Lyft's price target from $20.00 to $23.00 and kept a market perform rating, signaling about a 14.54% upside from the prior close. The update comes alongside other analyst movements, including Bank of America lifting its target from $12 to $14 with an underperform rating, Benchmark reiterating a Buy, and Deutsche Bank Aktiengesellschaft raising its target to $21 with a Hold rating. Market participants show a mixed tape: Wall Street Zen trimmed rating, Wedbush lifting to $20 with Neutral; overall Street consensus from MarketBeat sits at Hold with an average price target around $19.88. LYFT traded around $20.08 as investors digested the earnings report, where the company posted $0.13 per share vs $0.30 expected, with $1.69B revenue.
Graham (GHM) Q2 Earnings Miss vs. Estimate; Revenue Beats
November 7, 2025, 10:56 AM EST. Graham (GHM) reported Q2 earnings of $0.31 per share, short of the Zacks consensus of $0.33 and down from a year-ago $0.31. The quarterly result includes non-recurring adjustments and represents a -6.06% surprise. Revenue came in at $66.03 million, beating the street by 12.67% versus the prior year's $53.56 million. Management commentary on the call will drive the stock's near-term moves, with a YTD gain of around 39.7% vs. the S&P 500's 14.3%. Ahead, the current-quarter consensus is $0.27 on $52.61 million in revenue, and the full year is $1.42 on $230.61 million in revenue. The stock carries a Zacks Rank #3 (Hold), implying performance in line with the market in the near term.
Essent Group Q3 EPS Misses Estimates; Revenue Beat; Outlook Mixed
November 7, 2025, 10:52 AM EST. Essent Group (ESNT) posted Q3 earnings of $1.67 per share, missing the Zacks Consensus of $1.75 - a -4.57% surprise. Excluding non-recurring items, the result compares with $1.65 a year earlier. The quarter's revenue was $311.83 million, topping the consensus by 1.18% and edging down from the prior year's $316.58 million. Over the last four quarters, Essent has beat EPS estimates twice and revenue estimates three times. The stock has risen about 11.7% YTD, versus the S&P 500 gain of about 14.3%. Looking ahead, the current-quarter EPS is seen at $1.79 on $310.92 million in revenue, with the full year at $7.11 on $1.26 billion. Management commentary on the call will be key; the current Zacks Rank remains #3 Hold.